Networks of Excellence
In 2024 NHS England funded eight innovative networks to develop the evidence and model of adoption for cutting edge genomic advances and technology applications that will be transformative for patients.
The NHS Genomic Networks of Excellence are designed to be partnerships between the NHS, academia, the third sector and industry to leverage expertise and resources from the broader genomics ecosystem, and to ensure there is a route towards rapid informing commissioning decisions.
The 8 networks of excellence are:
- Prenatal genomic medicine
- Circulating tumour biomarker testing
- Haemato-oncology
- Rare and inherited disease
- Severe presentation of infectious disease
- Improving the identification and outcomes for individuals with inherited and acquired cardiovascular disease
- Pharmacogenomic and medicines optimisation
- Genomics artificial intelligence (AI)
More information about the Networks of Excellence can be found on the NHS England website.
The North Thames Genomic Medicine Service co-leads the following networks:
Prenatal genomic medicine
The prenatal genomic medicine network of excellence aims to ensure equity of access to high quality pre- and perinatal genomic medicine for all families across England, capitalising on new technological developments to deliver high quality testing for more conditions.
Circulating tumour biomarker testing